114 related articles for article (PubMed ID: 23432404)
1. Sertindole: dilemmas for its use in clinical practice.
Pae CU
Expert Opin Drug Saf; 2013 May; 12(3):321-6. PubMed ID: 23432404
[TBL] [Abstract][Full Text] [Related]
2. Drug safety and efficacy evaluation of sertindole for schizophrenia.
Karamatskos E; Lambert M; Mulert C; Naber D
Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
[TBL] [Abstract][Full Text] [Related]
3. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
[TBL] [Abstract][Full Text] [Related]
4. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
5. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
6. A review of the safety and tolerability of sertindole.
Hale AS
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S65-70. PubMed ID: 9690973
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sertindole in schizophrenia: a clinical review.
Zoccali RA; Bruno A; Muscatello MR
J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
[TBL] [Abstract][Full Text] [Related]
8. Sertindole in the long-term treatment of schizophrenia.
Hale AS; Azorin JM; Lemming OM; Mæhlum E
Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine.
Wilton LV; Heeley EL; Pickering RM; Shakir SA
J Psychopharmacol; 2001 Jun; 15(2):120-6. PubMed ID: 11448085
[TBL] [Abstract][Full Text] [Related]
10. A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Perquin L; Steinert T
CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangle.
Bech P; Tanghøj P; Andreasson K; Overø KF
Acta Psychiatr Scand; 2011 Feb; 123(2):154-61. PubMed ID: 20560900
[TBL] [Abstract][Full Text] [Related]
12. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia.
Azorin JM; Strub N; Loft H
Int Clin Psychopharmacol; 2006 Jan; 21(1):49-56. PubMed ID: 16317317
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
Kane JM; Potkin SG; Daniel DG; Buckley PF
J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
[TBL] [Abstract][Full Text] [Related]
16. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
17. The European Post-marketing Observational Serdolect (EPOS) Project: increasing our understanding of schizophrenia therapy.
Wehnert A
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S27-30. PubMed ID: 9690967
[TBL] [Abstract][Full Text] [Related]
18. Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophrenia.
Nielsen J; Matz J; Mittoux A; Polcwiartek C; Struijk JJ; Toft E; Kanters JK; Graff C
Eur Neuropsychopharmacol; 2015 Mar; 25(3):303-11. PubMed ID: 25583364
[TBL] [Abstract][Full Text] [Related]
19. Emerging treatments in the management of schizophrenia - focus on sertindole.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Settineri S; Zoccali R
Drug Des Devel Ther; 2010 Sep; 4():187-201. PubMed ID: 20856845
[TBL] [Abstract][Full Text] [Related]
20. Sertindole in schizophrenia: efficacy and safety issues.
Muscatello MR; Bruno A; Micali Bellinghieri P; Pandolfo G; Zoccali RA
Expert Opin Pharmacother; 2014 Sep; 15(13):1943-53. PubMed ID: 25084209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
